Search

everythinglearnresearchcommunity

for

Search:↓

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Hair transplantation can successfully treat stubborn alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Combining cyclosporine A and ketoconazole can effectively treat anal furunculosis in dogs, with some experiencing recurrences and mild side effects.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

A 5-year-old Akita with a rare skin condition improved significantly after treatment.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.